Mesenchymal stem cell therapy shows promise for treating MS, but more research is needed on long-term safety and efficacy, a ...

SUDO-550, an oral therapy for MS, was found to be safe and to reach the brain in its first human clinical trial, trial ...

A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 readouts ...

Roche's late-stage trial of fenebrutinib, a multiple sclerosis drug candidate, met its primary goal. The trial demonstrated a significant reduction in annualized relapse rates compared to ...

Doctors are looking to recruit more people for the trial, which they say could one day be given as a single one-off treatment ...

A biology teacher and mother-of-two has become the first UK patient to receive a "gamechanger" therapy to treat multiple sclerosis (MS). Emily Henders, 37, from Bushey, Hertfordshire, was treated at ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

Sandoz’s Tyruko (natalizumab), the only FDA approved natalizumab biosimilar for adults with relapsing multiple sclerosis and Crohn’s disease, is now available by prescription in the United States ...

There’s a spring in former Carson High School teacher Phil Brady’s step now that he doesn’t have to rely on his wheelchair ...

WALTHAM, Mass., May 29, 2024 /PRNewswire/ -- The iConquerMS™ People-Powered Research Network (PPRN) (www.iConquerMS.org), a research initiative of the Accelerated Cure Project (ACP), is partnering ...